Skip to main content

October 2017 - FRMC

Featured Article

News
10/26/2017
Dean Celia
Amazon is eyeing the pharmaceutical business; Apple has the attention of a big insurer; Google’s sister company is aiming to produce data-driven interventions— but what does it all mean for payers?
Amazon is eyeing the pharmaceutical business; Apple has the attention of a big insurer; Google’s sister company is aiming to produce data-driven interventions— but what does it all mean for payers?
Amazon is eyeing the...
10/26/2017
First Report Managed Care
News
10/26/2017
Mary Beth Nierengarten
Research and development in HIV treatment over the last decade has turned what was once a deadly disease into a treatable chronic condition. However, while groundbreaking new regimens are continually coming to the market in fewer daily doses,...
Research and development in HIV treatment over the last decade has turned what was once a deadly disease into a treatable chronic condition. However, while groundbreaking new regimens are continually coming to the market in fewer daily doses,...
Research and development in HIV...
10/26/2017
First Report Managed Care
Formulary Frontlines®
10/26/2017
Russell J. Spjut, PharmD
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
News
10/26/2017
Eileen Koutnik-Fotopoulos
Some formularies are pushing patients away from cheaper generics in favor of high cost generics. We spoke with some managed care experts to understand why this practice is in place for some insurers.
Some formularies are pushing patients away from cheaper generics in favor of high cost generics. We spoke with some managed care experts to understand why this practice is in place for some insurers.
Some formularies are pushing...
10/26/2017
First Report Managed Care
Managed Care Q&A
10/26/2017
Julie Gould; Zachary Bessette
Steve Miller, MD, MBA, chief medical officer of Express Scripts, discusses how payers are going to have to become innovative in order to pay the high prices associated with gene therapy.
Steve Miller, MD, MBA, chief medical officer of Express Scripts, discusses how payers are going to have to become innovative in order to pay the high prices associated with gene therapy.
Steve Miller, MD, MBA, chief...
10/26/2017
First Report Managed Care
News
10/26/2017
Dean Celia
Amazon is eyeing the pharmaceutical business; Apple has the attention of a big insurer; Google’s sister company is aiming to produce data-driven interventions— but what does it all mean for payers?
Amazon is eyeing the pharmaceutical business; Apple has the attention of a big insurer; Google’s sister company is aiming to produce data-driven interventions— but what does it all mean for payers?
Amazon is eyeing the...
10/26/2017
First Report Managed Care
Conference Insider
10/25/2017
During a presentation at the 2017 Clinical Pathways Congress, Alan Balch, PhD, explained that clinical pathway development needs to do a better job at taking the patient perspective into account when providing cancer care.
During a presentation at the 2017 Clinical Pathways Congress, Alan Balch, PhD, explained that clinical pathway development needs to do a better job at taking the patient perspective into account when providing cancer care.
During a presentation at the...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
Biosimilars occupy a huge place in the oncology treatment conversation these days. But what are they exactly, and how will they impact clinical pathways?
Biosimilars occupy a huge place in the oncology treatment conversation these days. But what are they exactly, and how will they impact clinical pathways?
Biosimilars occupy a huge place...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
During the keynote speech at the RAPS 2017 Regulatory Convergence, Scott Gottlieb, MD, commissioner of the FDA, explained that the agency is focused on making drug development more efficient and cheaper in order to expedite approvals and...
During the keynote speech at the RAPS 2017 Regulatory Convergence, Scott Gottlieb, MD, commissioner of the FDA, explained that the agency is focused on making drug development more efficient and cheaper in order to expedite approvals and...
During the keynote speech at the...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
Researcher presented at the European Association for the Study of Diabetes 2017 (EASD) in Lisbon, Portugal, highlighted the significant risk of death caused by hypoglycemia among patients with diabetes.
Researcher presented at the European Association for the Study of Diabetes 2017 (EASD) in Lisbon, Portugal, highlighted the significant risk of death caused by hypoglycemia among patients with diabetes.
Researcher presented at the...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
In order for biosimilars to relieve the impact of high cost specialty pharmacy drugs, more uptake and education is need for patients, providers, and payers, according to a presentation at the National Association of Specialty Pharmacy Annual...
In order for biosimilars to relieve the impact of high cost specialty pharmacy drugs, more uptake and education is need for patients, providers, and payers, according to a presentation at the National Association of Specialty Pharmacy Annual...
In order for biosimilars to...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
A new medication therapy management and pharmacy consultation service, the Ubuntu Pharmacist Care Program, helped to improve the continuum of care for patients with HIV, according to a presentation at the National Association of Specialty...
A new medication therapy management and pharmacy consultation service, the Ubuntu Pharmacist Care Program, helped to improve the continuum of care for patients with HIV, according to a presentation at the National Association of Specialty...
A new medication therapy...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
According to recent research presented at the National Association of Specialty Pharmacy Annual Meeting & Expo 2017, engagement with stakeholders in quality improvement and cost management initiatives for hemophilia specialty medications are...
According to recent research presented at the National Association of Specialty Pharmacy Annual Meeting & Expo 2017, engagement with stakeholders in quality improvement and cost management initiatives for hemophilia specialty medications are...
According to recent research...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
The emergence of new treatment options requires payers to expeditiously evaluate and adopt newer agents and pathways as they become available, according to research presented at the National Association of Specialty Pharmacy Annual Meeting &...
The emergence of new treatment options requires payers to expeditiously evaluate and adopt newer agents and pathways as they become available, according to research presented at the National Association of Specialty Pharmacy Annual Meeting &...
The emergence of new treatment...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
According to a presentation by Richard Brook and colleagues, payers are likely to favor less expensive, generically available agents until real-world data provides justification for use of PCSK9 inhibitors. 
According to a presentation by Richard Brook and colleagues, payers are likely to favor less expensive, generically available agents until real-world data provides justification for use of PCSK9 inhibitors. 
According to a presentation by...
10/25/2017
First Report Managed Care
Conference Insider
10/25/2017
The 2017 PCMH Congress, the NCQA’s annual meeting (November 3 – 5 at the Hyatt Regency in Orlando, Florida), is a chance for health care providers and decision makers to come together in order to gain a better understanding of the advances in...
The 2017 PCMH Congress, the NCQA’s annual meeting (November 3 – 5 at the Hyatt Regency in Orlando, Florida), is a chance for health care providers and decision makers to come together in order to gain a better understanding of the advances in...
The 2017 PCMH Congress, the...
10/25/2017
First Report Managed Care
News Connection
10/25/2017
HHS Secretary Tom Price, MD, has resigned following the controversy surrounding his use of private planes for government-related travel at a high cost to taxpayers.
HHS Secretary Tom Price, MD, has resigned following the controversy surrounding his use of private planes for government-related travel at a high cost to taxpayers.
HHS Secretary Tom Price, MD, has...
10/25/2017
First Report Managed Care
News Connection
10/25/2017
The CMS recently announced that Medicare Advantage is expected to enroll more members in 2018 and cost less than previous years.
The CMS recently announced that Medicare Advantage is expected to enroll more members in 2018 and cost less than previous years.
The CMS recently announced that...
10/25/2017
First Report Managed Care
News Connection
10/25/2017
Cigna, one of the nation’s largest insurers, has announced it will stop covering OxyContin in favor of an abuse-derrent formulation, Xtampza ER (oxycodone, Collegium), according to a recent press release.
Cigna, one of the nation’s largest insurers, has announced it will stop covering OxyContin in favor of an abuse-derrent formulation, Xtampza ER (oxycodone, Collegium), according to a recent press release.
Cigna, one of the nation’s...
10/25/2017
First Report Managed Care